...
首页> 外文期刊>International journal of clinical practice >Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience
【24h】

Antifungal step-down therapy based on hospital intravenous to oral switch policy and susceptibility testing in adult patients with candidaemia: a single centre experience

机译:基于医院的抗真菌降压疗法静脉对口服交换机政策和成年患者的敏感性检测:单一中心经验

获取原文
获取原文并翻译 | 示例
           

摘要

AimsEchinocandins are recommended for the treatment of candidaemia in moderately severe to severely ill patients. Step-down or de-escalation from echinocandin to fluconazole is advised in patients who are clinically stable but data in relation to step-down therapy are sparse. Using our hospital intravenous to oral switch therapy (IVOST) policy to guide antifungal de-escalation in patients with candidaemia, we aimed to determine what proportion of patients are de-escalated to fluconazole, the timescale to step-down, associated reduction in consumption of echinocandins and antifungal cost savings.
机译:AimsechinoCandins被推荐用于治疗中度严重的念珠菌,严重患者。 在临床稳定的患者中建议从echinocandin到氟康唑的降雨或脱升升级,但是与降压疗法有关的数据是稀疏的。 使用我们的医院静脉注重对口服切换治疗(ivost)政策导向念珠菌患者的抗真菌脱升升级,我们旨在确定患者的比例逐渐升级到氟康唑,时间尺度降低,消费减少 echinocandins和抗真菌成本节约。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号